CFDE Data Portal | Search LINC01801

	Label	Description
	LINC01801 Gene (Entity type)	ENSG00000267767 - long intergenic non-protein coding RNA 1801
	GSE120612 etoposide leukocyte 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 10 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE128076 doxycycline HEK293 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 6 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 7 v 15 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE261563 CX-5461 3 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE224004 GSE224005 CHD4 EWS-FLI1 knockdown 0 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE236502 paclitaxel 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE130401 trametinib YAP 6 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS

LINC01801

ENSG00000267767 - long intergenic non-protein coding RNA 1801

GSE120612 etoposide leukocyte 6 v 1 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 10 v 5 human dn

A Gene Set from LINCS

GSE128076 doxycycline HEK293 1 v 3 human dn

A Gene Set from LINCS

GSE143782 calcitriol 6 v 5 human up

A Gene Set from LINCS

GSE252944 AKT inhibition 7 v 15 human up

A Gene Set from LINCS

GSE261563 CX-5461 3 v 8 human up

A Gene Set from LINCS

GSE224004 GSE224005 CHD4 EWS-FLI1 knockdown 0 v 8 human up

A Gene Set from LINCS

GSE236502 paclitaxel 1 v 3 human dn

A Gene Set from LINCS

GSE130401 trametinib YAP 6 v 0 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.